One of the challenges in treating brain cancer and other diseases of the central nervous system is delivering therapeutics beyond the blood-brain barrier. NeOnc Technologies using a natural compound derived from essential oils in plants that not only can kill cancer cells, but can cross the blood-brain barrier. What’s more, it can transport other therapies as well. We spoke to Thomas Chen, founder and CEO of NeOnc, about brain cancer, how the blood-brain barrier complicates the delivery of therapies to treat the condition, and how its experimental candidate that is delivered intranasally works.
Fler avsnitt av The Bio Report
Visa alla avsnitt av The Bio ReportThe Bio Report med Levine Media Group finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
